This inventor holds 2 USPTO granted patents. Top assignees: Ablynx N.v., Merck Patent Gmbh, N.V., Ablynx. Active years: 2023-2026.
Company Filing History:
1 out of 174 
1 out of 3,021 
1 out of 3 Years Active: 2023-2026
Title: The Innovations of Hans Gühring
Introduction
Hans Gühring is a notable inventor based in Geisenheim, Germany. He has made significant contributions to the field of immunology, particularly through his innovative work on immunoglobulins that bind to Aggrecan. His research has implications for therapeutic and diagnostic applications.
Latest Patents
Hans Gühring holds a patent for "Aggrecan binding immunoglobulins." This invention relates to immunoglobulins that specifically bind Aggrecan, including polypeptides and nucleic acids encoding such polypeptides. The patent also covers methods for preparing these polypeptides and pharmaceutical compositions that utilize them for prophylactic, therapeutic, or diagnostic purposes. Notably, the immunoglobulins developed by Gühring inhibit the activity of Aggrecan.
Career Highlights
Throughout his career, Hans Gühring has worked with prominent companies in the pharmaceutical and biotechnology sectors. He has been associated with Ablynx N.V. and Merck Patent GmbH, where he has contributed to various innovative projects and research initiatives.
Collaborations
Hans Gühring has collaborated with esteemed colleagues, including Soren Steffensen and Gerald Beste. Their combined expertise has further advanced the research and development of immunoglobulin therapies.
Conclusion
Hans Gühring's contributions to immunology and his innovative patent on Aggrecan binding immunoglobulins highlight his role as a significant inventor in the field. His work continues to influence therapeutic approaches in medicine.